Skip to main content

Table 2 Diagnostic accuracy of intra-procedural CTHA-EM

From: A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis

 

First follow-up imaging, mRECIST

Non-complete response, i.e., partial response or stable disease (n = 19)

Complete response (n = 27)

CTHA-EM

Residual tumor

(n = 18)

18

0

Non-residual tumor

(n = 28)

1

27

  1. CTHA-EM Computed tomography hepatic arteriography enhancement mapping, mRECIST Modified response evaluation criteria in solid tumors